JUST IN: WHO suspends use of chloroquine for COVID-19 patients



The World Health (WHO), has announced temporary suspension clinical trials hydroxychloroquine, treatment patients.

Addressing a virtual press conference Geneva on Monday, the Director-General, Tedros Adhanom Ghebreyesus, disclosed the WHO-backed trials were “suspended while the safety is reviewed”.

“It’s important to continue to gather evidence on the efficacy and safety hydroxychloroquine.

“We want to use it if it’s safe and efficacious, reduces mortality, reduces the length of hospitalization increasing adverse events,” WHO Chief Scientist, Soumya Swaminathan, further explained.